April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
ROCK-2 Inhibition Supresses Choroidal Neovascularization
Author Affiliations & Notes
  • S. Zandi
    Ophthalmology, Angiogenesis Laboratory, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • S. Nakao
    Ophthalmology, Angiogenesis Laboratory, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • Y. Hata
    Ophthalmology, Kyushu University, Fukuoka, Japan
  • R. Arita
    Ophthalmology, Kyushu University, Fukuoka, Japan
  • D. Sun
    Ophthalmology, Angiogenesis Laboratory, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • L. Almulki
    Ophthalmology, Angiogenesis Laboratory, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • S. Frimmel
    Ophthalmology, Angiogenesis Laboratory, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • S. Faez
    Ophthalmology, Angiogenesis Laboratory, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • T. Ishibashi
    Ophthalmology, Kyushu University, Fukuoka, Japan
  • A. Hafezi-Moghadam
    Ophthalmology, Angiogenesis Laboratory, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  S. Zandi, None; S. Nakao, None; Y. Hata, None; R. Arita, None; D. Sun, None; L. Almulki, None; S. Frimmel, None; S. Faez, None; T. Ishibashi, None; A. Hafezi-Moghadam, None.
  • Footnotes
    Support  NIH grants HL086933 and AI050775, Massachusetts Lions Eye Research Fund Inc., Marion W. and Edward F. Knight AMD Fund, MPOB, and Research to Prevent Blindness.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 2985. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Zandi, S. Nakao, Y. Hata, R. Arita, D. Sun, L. Almulki, S. Frimmel, S. Faez, T. Ishibashi, A. Hafezi-Moghadam; ROCK-2 Inhibition Supresses Choroidal Neovascularization. Invest. Ophthalmol. Vis. Sci. 2010;51(13):2985.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Choroidal neovascularization (CNV) is the main cause of severe vision loss in patients with age-related macular degeneration (AMD). Previously we showed that rho kinase (ROCK) inhibition with fasudil reduced CNV size. However, the role of the ROCK isoforms, ROCK-1 and ROCK-2, in AMD is unknown. A novel specific ROCK-2 inhibitor (Surface Logix) was used to address this question.

Methods: : Animals were anesthetized and the pupils were dilated. CNV was induced with an argon laser. Four laser spots were placed in each eye using a slit lamp delivery system and a cover glass as a contact lens. The inhibitor or vehicle was injected intraperitoneally twice a day in three doses (1mg/kg, 10mg/kg, 30mg/kg).One week after laser injury animals were perfused with 10ml PBS and fluorescein-labeled dextran and flatmounts were prepared. The hyperfluorescent area, showing the CNV lesions, were measured with Openlab software.Inhibitors or vehicle were injected intravitreally using an Exmire microsyringe on days 0, 3, 7 after CNV induction. Vascular leakage from the CNV lesions was assessed using fluorescein angiography (FA), using a digital fundus camera.

Results: : Seven days after laser injury, systemic treatment with 10mg/kg (13000±2396µm², n=8) and 30mg/kg (9890±2926µm², n=8) of the ROCK-2 inhibitor caused a significant reduction in CNV size, compared with vehicle-treated controls (21471±1680µm², n=8, P=0.005, P=0.0008) and low dose ROCK-2 inhibitor (1mg/kg, 21972±3014µm², n=8). Intravitreal injection of fasudil or the ROCK-2 inhibitor one week after laser injury caused significantly smaller lesions than the vehicle-treated group (29818±4035µm², 33406±4325µm² vs 58620± 2642µm², n=16, P=0.00003, P=0.0002).FA showed a significantly reduced incidence of the clinically relevant grade IIB lesions with ROCK-2 inhibition (53.1%, n=8), compared with the vehicle-treated animals (84.4%, n=8, P <0.05).

Conclusions: : ROCK-2 inhibition effectively suppresses laser-induced CNV and leakage. Our results indicate that ROCK-2 may become an attractive molecular target in the prevention and treatment of AMD.

Keywords: choroid: neovascularization • age-related macular degeneration 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×